We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Glenmark Pharmaceuticals SA, a subsidary of Glenmark Pharmaceuticals Ltd (GPL),
has outlicensed its asthma drug GRC 3886 for $53 million to Teijin Pharma which
would allow the latter to develop and market the drug in Japan.
Venus Remedies Ltd, a Chandigarh-based Pharmaceutical Company, engaged in manufacture
of super specialty formulations in oncology and cephalosporin segments, has
entered into marketing tie up with Cadila Pharmaceuticals Ltd. According to
a release, the company has bagged a contract from Cadila Pharma to launch their
anticancer range with the company.
The Canadian government takes too long to lift its automatic ban on new medicines
and evidence shows that the policy of automatically banning new medicines harms
Canadians far more than it helps them, according to A Lethal Guardian: The Canadian
Government's Ban on Prescription Drugs, released today by The Fraser Institute.
Africa's biggest generic drugmaker Aspen Pharmacare has signed a nonexclusive
deal to manufacture and distribute life-prolonging HIV/AIDS drugs for U.S.-based
Gilead Sciences.
GPC Biotech AG, focused on discovering and developing new anticancer drugs,
and Ingenium Pharmaceuticals AG, with the therapeutic focus on pain, announced
the joint receipt of a grant totaling €2.2 million in committed funding
from the BMBF (German Ministry for Education and Research) through its BioChancePLUS
program.
Japan Tobacco and JT group
company Torii Pharmaceutical jointly announced on April 22 that they have agreed
to reorganize their pharmaceutical manufacturing facilities.
Nigerian drug regulator NAFDAC claims to have destroyed counterfeit
and copy drugs worth over NGN1bn (US$7.50mn) in recent months. The agency has
stated that the illegal drugs were seized from street peddlers, abandoned shipments
retrieved at ports and voluntary submissions.
A series of major reforms to Mexico's General Health Law,
which envisage tighter penalties against drug copying and so-called miracle
products, is shortly to be sent to the country's Senate.
European Union (EU) officials have outlined a strategy for mass vaccination
in the event of an epidemic, which will encourage private sector participation
in boosting vaccine stocks.
India's Union Ministry of Chemicals and Fertilisers has ordered exemption
to value-added tax (VAT) on 50 life-saving pharmaceutical products, which currently
carry a 4% tariff.